Most Clicked StoriesMore >


GSK gains FDA nod for type 2 diabetes drug

DiabetesPro SmartBrief | Apr 16, 2014

The FDA has granted GlaxoSmithKline approval for its Tanzeum drug to boost glucose control in type 2 diabetes patients. HealthDay News (04/15)


U.S. diabetes, prediabetes rates continue to climb, data show

DiabetesPro SmartBrief | Apr 15, 2014

FDA clears A1C test from Abbott Laboratories

DiabetesPro SmartBrief | Apr 16, 2014

Data: Fewer diabetes-related complications since 1990

DiabetesPro SmartBrief | Apr 17, 2014

Protein intake influences diabetes risk, study says

DiabetesPro SmartBrief | Apr 16, 2014

Diabetes in pregnancy may raise risk of birth defects

DiabetesPro SmartBrief | Apr 14, 2014

Study: Once-weekly exenatide improves A1C in diabetes

DiabetesPro SmartBrief | Apr 15, 2014

Mediterranean diet tied to better diabetes outcomes, review finds

DiabetesPro SmartBrief | Apr 18, 2014

Diabetes patients on atrasentan show lower albuminuria, BP

DiabetesPro SmartBrief | Apr 14, 2014

Rice consumption leads to better diet quality in study

DiabetesPro SmartBrief | Apr 17, 2014


Find DiabetesPro SmartBrief Issues by Date:



ADA News More >


29th Annual Clinical Conference on Diabetes -- Marco Island, Fla.

DiabetesPro SmartBrief | Apr 18, 2014

Free American Diabetes Association Safe at School Toolkit

DiabetesPro SmartBrief | Apr 17, 2014

Help your patients prevent type 2 diabetes

DiabetesPro SmartBrief | Apr 16, 2014

The Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach

DiabetesPro SmartBrief | Apr 15, 2014

Performance improvement continuing education opportunity!

DiabetesPro SmartBrief | Apr 14, 2014




Sign up for DiabetesPro SmartBrief



Designed specifically for health care professionals, DiabetesPro SmartBrief is a FREE, daily e-mail newsletter. It provides the latest news, trends, and technology updates that matter most to health care professionals. Learn more

Recent Poll view more polls


What type of continuing education opportunities do you participate in most?

Chart.